Get started
SHANDONG WEIGAO GROUP MEDICALSHANDONG WEIGAO GROUP MEDICALSHANDONG WEIGAO GROUP MEDICAL

SHANDONG WEIGAO GROUP MEDICAL

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

1066 chart

Key stats

Market capitalization
‪21.93 B‬HKD
Dividend yield (indicated)
3.74%
Price to earnings Ratio (TTM)
9.96
Basic EPS (TTM)
0.49HKD
Net income
‪2.21 B‬HKD
Revenue
‪14.62 B‬HKD
Shares float
‪2.42 B‬
Beta (1Y)
0.69

About SHANDONG WEIGAO GROUP MEDICAL

Sector
Health Technology
Industry
Medical Specialties
CEO
Rinan Cong
Website
weigaogroup.com
Headquarters
Weihai
Employees (FY)
‪12.52 K‬
Founded
1988
ISIN
CNE100000171
FIGI
BBG000LFJVD9
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. It operates through the following segments: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others. The Medical Device Products segment produces and sells clinical care, wound management, medical testing, anesthesia, surgical related products, and other consumables. The Orthopaedic Products segment focuses on the provision of orthopaedic products. The Interventional Products segment consists of tumour and blood vessel interventional instruments. The Pharma Packaging Products includes pre-filled syringes and flushing syringes. The Blood Management Products segment refers to blood collection, irradiation, storage, separation, and sterilization products. The Others segment pertains to the finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1066 is 5.00 HKD — it has increased by 3.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANDONG WEIGAO GROUP MEDICAL stocks are traded under the ticker 1066.
SHANDONG WEIGAO GROUP MEDICAL is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
1066 stock is 7.17% volatile and has beta coefficient of 0.69. Check out the list of the most volatile stocks — is SHANDONG WEIGAO GROUP MEDICAL there?
1066 earnings for the last quarter are 0.29 HKD per share, whereas the estimation was 0.29 HKD resulting in a 0% surprise. The estimated earnings for the next quarter are 0.19 HKD per share. See more details about SHANDONG WEIGAO GROUP MEDICAL earnings.
SHANDONG WEIGAO GROUP MEDICAL revenue for the last quarter amounts to ‪7.45 B‬ HKD despite the estimated figure of ‪7.79 B‬ HKD. In the next quarter revenue is expected to reach ‪6.91 B‬ HKD.
Yes, you can track SHANDONG WEIGAO GROUP MEDICAL financials in yearly and quarterly reports right on TradingView.
1066 stock has risen by 6.38% compared to the previous week, the month change is a 4.76% fall, over the last year SHANDONG WEIGAO GROUP MEDICAL has showed a 62.24% decrease.
1066 net income for the last quarter is ‪868.74 M‬ HKD, while the quarter before that showed ‪1.35 B‬ HKD of net income which accounts for −35.87% change. Track more SHANDONG WEIGAO GROUP MEDICAL financial stats to get the full picture.
Today SHANDONG WEIGAO GROUP MEDICAL has the market capitalization of ‪21.93 B‬, it has increased by 3.77% over the last week.
SHANDONG WEIGAO GROUP MEDICAL dividend yield was 2.39% in 2023, and payout ratio reached 37.09%. The year before the numbers were 1.43% and 26.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1066 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANDONG WEIGAO GROUP MEDICAL stock right from TradingView charts — choose your broker and connect to your account.
1066 reached its all-time high on Aug 6, 2020 with the price of 22.70 HKD, and its all-time low was 4.11 HKD and was reached on Jul 8, 2015.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has ‪12.52 K‬ employees. See our rating of the largest employees — is SHANDONG WEIGAO GROUP MEDICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANDONG WEIGAO GROUP MEDICAL technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANDONG WEIGAO GROUP MEDICAL stock shows the sell signal. See more of SHANDONG WEIGAO GROUP MEDICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHANDONG WEIGAO GROUP MEDICAL future price: according to them, 1066 price has a max estimate of 8.70 HKD and a min estimate of 6.40 HKD. Read a more detailed SHANDONG WEIGAO GROUP MEDICAL forecast: see what analysts think of SHANDONG WEIGAO GROUP MEDICAL and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANDONG WEIGAO GROUP MEDICAL EBITDA is ‪3.46 B‬ HKD, and current EBITDA margin is 23.93%. See more stats in SHANDONG WEIGAO GROUP MEDICAL financial statements.